deltatrials
Suspended NA INTERVENTIONAL 2-arm NCT06002282

HPV Vaccine Confident Families

Sponsor: National Cancer Institute (NCI)

Conditions Human Papillomavirus Vaccines
Interventions Standard messages Tailored messages
Updated 4 times since 2023 Last updated: Aug 6, 2025 Started: Oct 31, 2025 Primary completion: Jun 30, 2026 Completion: Jul 31, 2026
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Suspended

NIH grant termination

Listed as NCT06002282, this NA trial focuses on Human Papillomavirus Vaccines and remains suspended. Sponsored by National Cancer Institute (NCI), it has been updated 4 times since 2025, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Sep 2023 – ~Jul 2024 · 10 months · monthly snapshotNot Yet Recruiting~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshotNot Yet Recruiting~Sep 2025 – present · 10 months · monthly snapshotSuspended

Change History

4 versions recorded

  1. Sep 2025 — Present [monthly]

    Suspended NA

    Status: Not Yet Recruiting → Suspended

  2. Sep 2024 — Sep 2025 [monthly]

    Not Yet Recruiting NA

  3. Jul 2024 — Sep 2024 [monthly]

    Not Yet Recruiting NA

  4. Sep 2023 — Jul 2024 [monthly]

    Not Yet Recruiting NA

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • National Cancer Institute (NCI)
  • Rutgers, The State University of New Jersey
Data source: Rutgers, The State University of New Jersey

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations